Research Applications for Iverjohn 6 mg Laboratory Studies
Iverjohn 6 mg is a research-grade antiparasitic compound manufactured by Johnlee Pharmaceuticals for in-vitro laboratory investigation. This standardised formulation enables researchers to examine ivermectin’s mechanism of action across multiple research protocols. Laboratory professionals studying antiparasitic pathways utilise this preparation to investigate molecular interactions with gamma-aminobutyric acid (GABA) receptor systems in controlled experimental conditions. Research applications include examining dose-response relationships, bioavailability parameters, and comparative pharmacokinetic profiles.
Academic institutions investigating parasitology rely on standardised preparations for reproducible research outcomes. Scientists at Stroid UK Shop examine this compound’s effects on chloride ion channel function within experimental models. Laboratory studies focus on evaluating selectivity profiles between mammalian and invertebrate GABA receptors. Researchers studying antiviral mechanisms investigate potential secondary pathways beyond established antiparasitic activity.
Analytical Research Specifications
Each Iverjohn 6 mg tablet provides consistent dosing for laboratory evaluation protocols. Research teams compare this preparation against reference standards to establish analytical benchmarks. Stability studies examine degradation patterns under various storage conditions to optimise research workflows. Comparative research includes evaluating formulation differences between manufacturers to establish research-grade criteria. Scientists studying receptor selectivity utilise this compound alongside other research tools for comprehensive pathway analysis.
| Parameter | Value |
|---|---|
| Active Ingredient | Ivermectin 6 mg |
| Manufacturer | Johnlee Pharmaceuticals |
| Form | Tablet |
| CAS Number | 70288-86-7 |
| Molecular Formula | C₄₈H₇₄O₁₄ |
Research teams studying bioactive compounds incorporate this preparation into broader investigational frameworks examining receptor-mediated pathways.
Research Compliance Statement
Iverjohn 6 mg tablets from Johnlee Pharmaceuticals are supplied exclusively for laboratory research purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with institutional guidelines and appropriate safety protocols when handling this research compound.
